ASSEMBLY BIOSCIENCES, INC.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We lease office space for corporate and administrative functions and laboratory space in South San Francisco, California under a sublease that expires in September 2029.
We believe these leased facilities are adequate for our current needs and that additional space will be available in the future on commercially reasonable terms as needed.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.